Results 111 to 120 of about 53,179 (222)

Arrhythmias After Tetralogy of Fallot Repair [PDF]

open access: yes, 2005
Tetralogy of Fallot is the most common cyanotic congenital heart disease, with a good outcome after total surgical correction. In spite of a low perioperative mortality and a good quality of life, late sudden death remains a significant clinical problem,
Daliento, Luciano   +1 more
core   +1 more source

Determination of Intrinsic Mode and Linear Mode Coupling in Solar Microwave Bursts

open access: yes, 2013
An explicit equation of the propagational angle of microwave emission between the line-of-sight and the local magnetic field is newly derived. The existence of the solution of propagational angle is clearly shown under a series of typical parameters in ...
Huang, Guangli, Li, Jianping, Song, Qiwu
core   +1 more source

A novel treatment of biogas digestate waste for biochar production and its adsorption of methylene blue and malachite green in a binary system

open access: yesBiofuels, Bioproducts and Biorefining, EarlyView.
Abstract This study presents a novel treatment of biogas digestate to produce biochar at processing temperatures of 500–700 °C. The resulting biochar was applied for the simultaneous removal of methylene blue (MB) and malachite green (MG) in a binary system.
Van Hau Duong   +10 more
wiley   +1 more source

Effect of Inpatient Cardiac Rehabilitation on QT Dispersion in Patients with Acute Myocardial Infarction

open access: yesActa Medica Iranica, 2013
QT dispersion is an indicator of lack of ventricular repolarization homogeneity and an independent predictor for ventricular arrhythmia and sudden cardiac death.
Zahra Ansari   +5 more
doaj  

Pharmacokinetics, pharmacodynamics and safety of casdatifan, a novel hypoxia‐inducible factor‐2α inhibitor, in healthy participants

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Casdatifan is an orally bioavailable small‐molecule hypoxia‐inducible factor‐2α (HIF‐2α) inhibitor currently in development for treating patients with clear cell renal cell carcinomas. The aim of this study was to characterize the pharmacokinetics (PK), pharmacodynamics and safety of casdatifan in healthy participants.
Mohammad Ghasemi   +11 more
wiley   +1 more source

Weighing the QT Intervals with the Slope or the Amplitude of the T Wave

open access: yesAnnals of Noninvasive Electrocardiology, 2001
Objective: The reproducibility of QT interval measurements is low, even for the mean QT interval based on the standard ECG. In this study we analyzed whether the reproducibility of the mean weighed QT interval was better than the simple mean QT interval.
Kaspar Lund   +2 more
doaj   +1 more source

Comparison of QT dispersion before and after PDA device closure in pediatrics. [PDF]

open access: yesAnn Noninvasive Electrocardiol, 2022
Khalilian MR   +4 more
europepmc   +1 more source

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun   +4 more
wiley   +1 more source

QT Dispersion and Drug-Induced Torsade de Pointes. [PDF]

open access: yesCureus, 2021
Friedman A   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy